<pre>Diabetes mellitus is a chronic disease caused by high levels of blood glucose. A high-fat diet can cause hyperglycemia .Hyperglycemia will cause the formation of free radicals which can damage cells. Aloksan is a chemical that can damage beta cells, resulting in decreased insulin production. Ketapang (<em>Terminalia catappa</em>) is a plant that can be used because of its antioxidant content. The administration of ketapang extract (<em>Terminalia catappa</em>) is thought to reduce levels of malondialdehyde. Malondialdehyde is a biomarker for the occurrence of lipid peroxidation in the body caused by an increase in free radicals due to the occurrence of oxidative stress.</pre><p> This study used Wistar rats divided into 4 groups. Three groups will be given high-fat diet for 7 days followed by induced alloxan at a dose of 90 mg / kgBW to increase blood glucose levels and pancreatic malondialdehyde levels. Then 2 groups will be given treatment for 14 days. The first treatment group was given Ketapang extract with a dose of 600 mg / kgBW and the second treatment group which was given glibenclamide using a dose of 0.09 mg / kgBW.</p><pre> The results showed that there was a significant decrease in pancreatic malondialdehyde in Wistar rats induced by glibenclamide (p = 0.016). In the group induced by ketapang leaf and fruit extract (Terminalia catappa) there was a decrease in malondialdehyde levels but was not significant (p = 0.916).</pre><p> Conclusions, this study indicated that the administration of ketapang leaf and fruit (<em>Terminalia catappa</em>) extract were able to reduce the levels of pancreatic malondialdehyde given a high-fat diet and induced by alloxan.</p><p> </p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.